Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00090740
Status:
COMPLETED
Last Update Posted:
2013-01-25
First Post:
2004-09-03
Brief Title:
Genetic Risk Factors for Severe Asthma
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Study Overview
Official Title:
Genetic Risk Factors for Severe Asthma
Status:
COMPLETED
Status Verified Date:
2013-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether a specific genetic factor influences the severity of asthma symptoms
Detailed Description:
Asthma is one of the most common chronic diseases in the United States It is well known that asthma susceptibility is inherited however it is unknown if asthma severity is heritable Studies suggest that levels of interleukin-16 IL-16 may influence asthma severity This study will examine the role of differences in the control region of the IL-16 gene in a racially diverse group of asthmatics and nonasthmatics and will determine if the IL-16 gene control region is related to asthma severity
Participants in this study will undergo lung function and blood tests they will also complete a questionnaire about their respiratory health Asthmatic participants will complete a severity-of-asthma questionnaire
Participants in this study will undergo lung function and blood tests they will also complete a questionnaire about their respiratory health Asthmatic participants will complete a severity-of-asthma questionnaire
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None